A global online educational platform sharing the latest research and emerging treatment information in multiple myeloma

Latest Drug Updates

Patients eligible for transplant,Patients non-eligible for transplant,Relapsed/refractory patients

Galinpepimut-S granted FDA orphan drug designation

May 11, 2018
Patients eligible for transplant,Patients non-eligible for transplant

Daratumumab approved by FDA for frontline use

May 8, 2018
Relapsed/refractory patients

Selinexor receives FDA fast track designation 

Apr 13, 2018

Where we are next

European School of Haematology (ESH) 4th International Conference on Multiple Myeloma

October 5–7, 2018 | Mandelieu, FR

The MM Hub will be attending the European School of Hematology (ESH) 4th International Conference on Myeloma, to be held in Mandelieu, France, from 5-7 October 2018. The meeting will be chaired by Kenneth C. Anderson, Maria Victoria Mateos, and Philippe Moreau, and will take place in the Congress Mandelieu Expo Center. The meeting attracts world-class leaders who present the latest clinical data and debate important and contentious issues in MM. 
#mmsm

Event Website

Connect with us

Our sister hubs

Visit our other community physician education hubs in haematology and oncology